News

Clinical Oncology Society of Australia launches teletrial guide

To improve access to clinical trials closer to home for rural and regional patients and patients with rare cancers even within large metro settings, Clinical Oncology Society of Australia (COSA) has developed and released the Australasian Tele trial model: National guide for implementation.  This model and guide were developed in collaboration with clinical trial sponsors (cooperative trial groups, Medicine Australia and pharmaceutical companies), clinicians, cancer centres, research organisations, health administrators and regulatory bodies.

The model uses the existing telehealth platforms to enable clinicians from larger centres (primary sites) to enrol, consent and treat patients on clinical trials at regional and rural centres (satellite sites). The benefits are not limited to regional and rural areas, with the same model having the potential to connect larger centres (even within the same city) and improve the rate of recruitment to highly specialised clinical trials such as those for rare cancers. Next steps include the adoption of the Australasian Tele‐trial Model as part of standard practice by cooperative trials groups, industry, researchers, governments, regulatory bodies, hospitals and insurers and streamlining of governance and regulatory processes. COSA Teletrial Consortium steering committee co-chaired by Professors Sabe Sabesan (sabe.sabesan@health.qld.gov.au) and John Zalcberg (john.zalcberg@monash.edu) will be coordinating the implementation at national level.